Who to call at Evotec, and when
Fundz watches for the moments Evotec starts buying, and tells you who to reach.
- An alert the day Evotec raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Evotec, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Evotec. With Fundz connected, it knows.
Evotec secures second FDA clearance for drug candidate under partnership with Bristol Myers Squibb.
Contract Type
partnership
Description
Evotec SE announced that the FDA has accepted a second IND application as part of its partnership with Bristol Myers Squibb. This development marks a significant milestone in their collaboration aimed at advancing innovative drug candidates in oncology.
Quick answer
Evotec secures second FDA clearance for drug candidate under partnership with Bristol Myers Squibb. (November 19, 2026). Evotec is based in Hamburg, Hamburg, Germany.
- What agreement did Evotec announce on November 19, 2026?
- Evotec SE announced that the FDA has accepted a second IND application as part of its partnership with Bristol Myers Squibb. This development marks a significant milestone in their collaboration aimed at advancing innovative drug candidates in oncology.
- What does Evotec do?
- Evotec is a biotechnology company that is committed to advancing drug discovery and development.
- Where is Evotec based?
- Evotec is based in Hamburg, Hamburg, Germany.
- Which similar companies announced agreements around the same time?
- AstraZeneca Pharma India (November 17, 2026), Pfizer (November 14, 2026), Spektus Pharma (November 13, 2026) and Sino Biopharmaceutical (November 13, 2026) also announced agreements within 45 days of Evotec.
Source: Fundz verified event record.
Other recent agreements in Pharmaceutical and Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- AstraZeneca Pharma India Forms Partnership with Strand Life Sciences for Healthcare Collaboration. (November 17, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- Spektus Pharma and GEBRO Holding Form Partnership for Global Commercialisation of ActraFlex® (November 13, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Daiichi Sankyo and iDEL Therapeutics Forge Global Research Partnership for Cancer Drug Development. (November 10, 2026)
- Essential Pharma and Nordmark establish partnership for UK availability of Norzyme® capsules for pancreatic insufficiency. (November 9, 2026)
Related People
Agreement Insights
What this usually meansEvotec signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.